Bath & Body Works, Inc. $BBWI Shares Acquired by Ameritas Investment Partners Inc.

Ameritas Investment Partners Inc. boosted its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 111.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 89,977 shares of the company’s stock after purchasing an additional 47,363 shares during the period. Ameritas Investment Partners Inc.’s holdings in Bath & Body Works were worth $2,696,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Stonehage Fleming Financial Services Holdings Ltd purchased a new stake in shares of Bath & Body Works in the second quarter worth about $33,000. SVB Wealth LLC acquired a new position in Bath & Body Works during the 1st quarter worth approximately $35,000. Geneos Wealth Management Inc. boosted its holdings in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC boosted its holdings in Bath & Body Works by 63.3% in the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after acquiring an additional 481 shares during the period. Finally, Parkside Financial Bank & Trust grew its position in Bath & Body Works by 24.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after acquiring an additional 364 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Jefferies Financial Group reduced their target price on shares of Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a research report on Monday, October 13th. Wall Street Zen lowered shares of Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Wells Fargo & Company lowered their target price on Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday. New Street Research set a $26.00 price target on Bath & Body Works in a research note on Monday. Finally, Citigroup reduced their price target on Bath & Body Works from $35.00 to $21.00 and set a “buy” rating for the company in a report on Friday. Seven research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to MarketBeat.com, Bath & Body Works currently has an average rating of “Hold” and a consensus target price of $26.84.

Insider Buying and Selling

In other Bath & Body Works news, Director Lucy Brady acquired 3,470 shares of Bath & Body Works stock in a transaction dated Friday, November 21st. The stock was acquired at an average cost of $14.40 per share, for a total transaction of $49,968.00. Following the completion of the transaction, the director owned 17,482 shares in the company, valued at approximately $251,740.80. This represents a 24.76% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Francis Hondal acquired 3,343 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The stock was acquired at an average cost of $14.99 per share, with a total value of $50,111.57. Following the completion of the acquisition, the director directly owned 21,554 shares in the company, valued at approximately $323,094.46. This represents a 18.36% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased a total of 33,513 shares of company stock valued at $500,442 over the last three months. 0.26% of the stock is owned by company insiders.

Bath & Body Works Price Performance

Shares of BBWI opened at $15.58 on Tuesday. The stock has a market capitalization of $3.21 billion, a PE ratio of 4.62, a price-to-earnings-growth ratio of 0.86 and a beta of 1.53. The business’s fifty day moving average price is $24.37 and its 200 day moving average price is $28.00. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $41.87.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company posted $0.49 earnings per share. The firm’s revenue for the quarter was down 1.0% on a year-over-year basis. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS. Q4 2025 guidance at 1.700- EPS. As a group, research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 5.1%. The ex-dividend date is Friday, November 21st. Bath & Body Works’s payout ratio is presently 24.62%.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.